Sarasin & Partners LLP Merck & Co., Inc. Transaction History

Sarasin & Partners LLP

$10.6 Billion
Q3 2024

A detailed history of Sarasin & Partners LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 1,884,285 shares of MRK stock, worth $187 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

1,884,285

Previous 2,268,362 16.93%

Holding current value

$187 Million

Previous $281 Million 23.8%

% of portfolio

2.02%

Previous 2.49%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$111.15 - $128.97 $42.7 Million - $49.5 Million	-384,077 Reduced 16.93%	1,884,285 $214 Million
Q2 2024 Jul 19, 2024	SELL	$123.8 - $132.96 $66.8 Million - $71.8 Million	-539,785 Reduced 19.22%	2,268,362 $281 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $5.62 Million - $6.55 Million	-49,648 Reduced 1.74%	2,808,147 $371 Million
Q4 2023 Jan 09, 2024	SELL	$100.18 - $109.02 $44 Million - $47.9 Million	-439,635 Reduced 13.33%	2,857,795 $312 Million
Q3 2023 Oct 05, 2023	BUY	$102.95 - $114.33 $10.8 Million - $12 Million	104,812 Added 3.28%	3,297,430 $339 Million
Q2 2023 Jul 10, 2023	BUY	$108.61 - $118.38 $217,220 - $236,760	2,000 Added 0.06%	3,192,618 $368 Million
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $91.9 Million - $103 Million	-893,009 Reduced 21.87%	3,190,618 $339 Million
Q1 2023 Apr 27, 2023	BUY	$102.94 - $114.86 $96.3 Million - $107 Million	935,446 Added 29.71%	4,083,627 $434 Million
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $44.3 Million - $56.8 Million	-506,208 Reduced 13.85%	3,148,181 $349 Million
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $9.28 Million - $10.4 Million	-109,832 Reduced 2.92%	3,654,389 $315 Million
Q2 2022 Jul 13, 2022	SELL	$83.49 - $94.64 $95.2 Million - $108 Million	-1,139,901 Reduced 23.24%	3,764,221 $343 Million
Q1 2022 Apr 11, 2022	BUY	$73.51 - $82.4 $61 Million - $68.4 Million	829,901 Added 20.37%	4,904,122 $402 Million
Q4 2021 Jan 19, 2022	BUY	$72.28 - $90.54 $24.1 Million - $30.2 Million	333,906 Added 8.93%	4,074,221 $312 Million
Q3 2021 Oct 22, 2021	BUY	$71.68 - $78.83 $21.4 Million - $23.5 Million	298,313 Added 8.67%	3,740,315 $281 Million
Q2 2021 Jul 13, 2021	BUY	$70.31 - $77.77 $34.1 Million - $37.7 Million	484,963 Added 16.4%	3,442,002 $268 Million
Q1 2021 Apr 29, 2021	BUY	$68.86 - $81.11 $36.7 Million - $43.2 Million	532,984 Added 21.99%	2,957,039 $228 Million
Q4 2020 Jan 19, 2021	BUY	$71.77 - $79.65 $12.1 Million - $13.4 Million	168,014 Added 7.45%	2,424,055 $198 Million
Q3 2020 Nov 09, 2020	BUY	$73.18 - $82.95 $32.3 Million - $36.6 Million	441,331 Added 24.32%	2,256,041 $187 Million
Q2 2020 Jul 17, 2020	BUY	$70.42 - $80.13 $105 Million - $119 Million	1,489,720 Added 458.39%	1,814,710 $140 Million
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $15.9 Million - $22 Million	250,299 Added 335.11%	324,990 $25 Million
Q3 2019 Nov 08, 2019	BUY	$76.08 - $82.93 $953,891 - $1.04 Million	12,538 Added 20.17%	74,691 $6.29 Million
Q2 2019 Jul 18, 2019	BUY	$69.84 - $81.59 $1.72 Million - $2.01 Million	24,594 Added 65.48%	62,153 $5.21 Million
Q4 2018 Feb 12, 2019	SELL	$65.24 - $75.71 $1.09 Million - $1.27 Million	-16,714 Reduced 30.8%	37,559 $2.87 Million
Q3 2018 Nov 09, 2018	BUY	$57.69 - $67.84 $3.13 Million - $3.68 Million	54,273 New	54,273 $3.85 Million

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.

Account

Sarasin & Partners LLP Merck & Co., Inc. Transaction History